Philip Morris to Acquire Syqe Medical
- Featured Mergers and Acquisitions News This Week
- July 19, 2023
- 0
- 1 minute read
![Philip Morris to Acquire Syqe Medical](https://files.tobaccoreporter.com/wp-content/uploads/sites/2/2022/11/deal-handshake-850x560.jpg)
![](https://files.tobaccoreporter.com/wp-content/uploads/sites/2/2022/11/deal-handshake-1024x683.jpg)
Philip Morris International plans to acquire Syqe Medical, an Israeli company, according to Calcalist. The deal could reach $650 million.
Syqe’s main product is a metered-dose inhaler for pain reduction using medical marijuana.
PMI will initially invest $120 million to aid in the process of obtaining U.S. Food and Drug Administration approval for Syqe’s inhaler. If approval is received, PMI will purchase all shares of Syqe for $650 million.
PMI subsidiary Vectura will conduct the transaction.
In 2016, PMI invested $20 million in Syqe.